Bone Biologics Corp (BBLG) › Operating Cash FlowBone Biologics Corp (BBLG) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$5.7K2011: -$3.6K2012: -$6.1K2013: -$525.4K2014: -$2.76M2015: -$3.55M2016: -$7.33M2017: -$3.33M2018: -$4.10M2019: -$3.25M2020: -$426.9K2021: -$1.23M2022: -$3.57M2023: -$9.56M2024: -$4.12M2025: -$2.69M-$2.69M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$2.69M+34.8%2024-$4.12M+56.8%2023-$9.56M-167.9%2022-$3.57M-190.3%2021-$1.23M-187.8%2020-$426.9K+86.9%2019-$3.25M+20.8%2018-$4.10M-23.3%2017-$3.33M+54.6%2016-$7.33M-106.7%2015-$3.55M-28.7%2014-$2.76M-424.5%2013-$525.4K-8573.7%2012-$6.1K-68.4%2011-$3.6K+36.7%2010-$5.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share